DYRK1A: A Potential Drug Target for Multiple Down Syndrome Neuropathologies

Publisher： Bentham Science Publishers

E-ISSN： 1996-3181|13|1|26-33

ISSN： 1871-5273

Source： CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol.13, Iss.1, 2014-02, pp. : 26-33

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

TRPV1 Channel: A Potential Drug Target for Treating Epilepsy

By  

Current Neuropharmacology, Vol. 13, Iss. 2, 2015-03 ,pp. : 239-247

Bentham Science Publishers

Access to resources Recommend Favorite

Protein-Tyrosine Phosphatase 1B as a Potential Drug Target for Obesity

By  

Current Drug Targets - Immune, Endocrine & Metabolic Disorders, Vol. 3, Iss. 4, 2003-12 ,pp. : 299-304

Bentham Science Publishers

Access to resources Recommend Favorite

The Role of YY1 in Oncogenesis and Its Potential as a Drug Target in Cancer Therapies

By  

Current Cancer Drug Targets, Vol. 15, Iss. 2, 2015-02 ,pp. : 145-157

Bentham Science Publishers

Access to resources Recommend Favorite

Immunoproteasome in Cancer and Neuropathologies: A New Therapeutic Target?

By  

Current Pharmaceutical Design, Vol. 19, Iss. 4, 2013-02 ,pp. : 702-718

Bentham Science Publishers

Access to resources Recommend Favorite

Phosphodiesterase-4 as a potential drug target

By Zhang Kam YJ   Ibrahim Prabha N   Gillette Sam   Bollag Gideon  

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 6, 2005-12 ,pp. : 1283-1305

Informa Healthcare

Access to resources Recommend Favorite